Respiratory
“New innovations are undergoing in our research centre for a number of products and services for various respiratory disease. ”
Respiratory diseases are some of the most common medical conditions in the world. Chronic obstructive pulmonary disease (COPD) accounts for 5% of global deaths annually (WHO). Asthma is the most common no communicable disease in children, with more than 230 million sufferers of all ages worldwide (WHO). We offer a number of products and services for various respiratory disease. Also new innovations are also undergoing in our research centre for the same.
Asthma & respiratory drugs we are offering formulation of api Bambuterol, Ephedrine , Theophylline, Ketotifen, Levosalbutamol, Modadinil , Montelukast Sodium, Salbutamol, Etophylline, Diazepam etc. in different combination & dosage form like tablets ( sugar coated/ enteric coated/ film coated/ extended release/ slow release/ dispersible tablets/ effervescent tablets), capsule, injection, creams, ointment, syrup, ampoule, liquid tonics, powder, sachets, granules, ors powder etc.
